Urinary catheterization is the insertion of a tube through the urethra into the bladder to empty or flush the bladder. Catheterization is preferred in patients with urinary retention and urinary incontinence, in patients who will undergo surgical intervention or in cases where a procedure needs to be performed in the urinary tract, and is applied for short (1-7 days), medium (7-28 days) and long term (longer than 28 days) (National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Urinary catheterization is frequently preferred in applications related to treatment and care. According to the CAUTI report, the frequency of urinary catheterization in hospitalized patients in one year is between 15-25% in the world. This rate is between 10-15% in developed countries and 20-30% in developing countries (CAUTI, 2015).
Inpatients in the Urology Clinic
Conscious and oriented patients
Patients aged 18-75 years
Patients with short-term catheterization
Patients who incompletely completed the data collection tool
Patients with hearing, vision and comprehension problems,
Parallel
e-book
BehavioralPatients with pilot application will not be included in the study. Patients who agree to participate in the study will be informed by the researcher about the purpose and process of the study, and their written and verbal informed consent will be obtained. Patients will be informed that the decision on whether or not to participate in the study is entirely their own, that no money will be deducted from their health insurance or any money will be paid to them, that the data to be collected from this study will only be used within the scope of the research, and that confidentiality will be strictly ensured. Pretests (Personal Information Form, Urinary Catheter Self-Efficacy Scale and Comfort Scale) will be administered to the patients whose consent is obtained.
First Follow-up (Personal Information Form, Urinary Catheter Self-Efficacy Scale and Comfort Scale
Pretest (Descriptive statistics will be shown with frequencies and percentages, and the distribution of variables according to scale scores will be shown with median (minimum-maximum) values.
Second Follow-up (Urinary Catheter Self-Efficacy Scale and Comfort Scale)
Second Follow-up . The conformity of the data to normal distribution will be evaluated by Kolmogrov Smirnow test and Mann-Whitney U and Kruskal-Wallis tests, which are non-parametric tests, will be used to compare variables that do not conform to normal distribution. Normally distributed data will be evaluated with t test and Anova test. In order to determine the differences in variables with more than two groups, the Dunn-Bonferroni test from Post-Hoc tests will be used. The relationship between self-efficacy and comfort level will be determined by Spearman Correlation Coefficient. Significance level p\<0.05 will be taken in the tests.
Third Follow-up(Urinary Catheter Self-Efficacy Scale and Comfort Scale)
Third Follow-up . The conformity of the data to normal distribution will be evaluated by Kolmogrov Smirnow test and Mann-Whitney U and Kruskal-Wallis tests, which are non-parametric tests, will be used to compare variables that do not conform to normal distribution. Normally distributed data will be evaluated with t test and Anova test. In order to determine the differences in variables with more than two groups, the Dunn-Bonferroni test from Post-Hoc tests will be used. The relationship between self-efficacy and comfort level will be determined by Spearman Correlation Coefficient. Significance level p\<0.05 will be taken in the tests.
Map coordinates are unavailable for these locations. Locations are shown below instead.
Click on the lead sponsor to view all of their trials.
